BillionToOne, Inc. (BLLN) Investor Relations Documents

BillionToOne, Inc. (BLLN) investor relations documents from the company's IR site: 4 presentations, 33 press releases; latest deck 2026-08-05. Read in-app with summaries. First-party data.

Presentation: BillionToOne, Inc. Q2 2026 update shows $109.4M revenue (64% YoY) and 70.5% gross margin, achieving $5.5M GAAP income.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-18Press release/C O R R E C T I O N -- BillionToOne/
2026-08-18Press releaseLargest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary
2026-08-05Press releaseBillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
2026-08-05PresentationPresentation
2026-07-20Press releaseBillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
2026-07-15Press releaseBillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-15Press releasePress ReleasesJuly 15, 2026BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026Read Article
2026-06-29Press releaseBillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for C
2026-06-29Press releasePress ReleasesJune 29, 2026BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Sta
2026-05-27Press releaseBillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
2026-05-27Press releasePress ReleasesMay 27, 2026BillionToOne to Participate in the William Blair 46th Annual Growth Stock ConferenceRead Artic
2026-05-06Press releaseBillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance
2026-05-06PresentationPresentation
2026-05-01Press releaseBillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagn
2026-04-15Press releaseBillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
2026-04-15Press releasePress ReleasesApril 15, 2026BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026Read Article
2026-04-02Press releaseBillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
2026-03-04Earnings deckPresentation
2026-03-04Press releasePress ReleasesMarch 4, 202620262026BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenu
2026-02-17Press releaseBillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
2026-02-17Press releasePress ReleasesFebruary 17, 2026BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 20
2026-02-10Press releaseBillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®
2026-01-15Press releaseBillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare
2026-01-15Press releasePress ReleasesJanuary 15, 2026BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Acr
2026-01-12Press releaseBillionToOne Provides Guidance for 2026
2025-12-23Press releaseBillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Press releasePress Release
2025-12-09Press releaseBillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair
2025-12-09PresentationPresentation
2025-11-15Regulatory reportCLIA: 05D2275351
2025-11-07Press releaseBillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase
2025-11-05Press releaseBillionToOne Announces Pricing of Upsized Initial Public Offering
2025-10-29Press releaseBillionToOne Announces Launch of Initial Public Offering Roadshow
2025-10-10Press releaseNew Study Showed Unnecessary Burden From Continued Monitoring of Alloimmunized Pregnancies With Antigen-Negative Fetuses
2025-08-26Press releaseBillionToOne's Northstar Select® Demonstrates Superior Sensitivity in Prospective Head-to-Head Validation Study Publicat
2025-08-15Regulatory reportPA: 40795
2025-08-15Regulatory reportPA: 37021
2025-08-01Press releaseBillionToOne Expands Executive Team to Support Growth of UNITY and Northstar Platforms
2025-05-15Press releaseBillionToOne Expands Executive Team with Dr. Haywood Brown as Chief Medical Officer, Prenatal
2025-03-18Press releaseBillionToOne Celebrates Major Milestone: 1 Million UNITY Tests

BLLN overview · BLLN earnings · BLLN financials · BLLN KPIs · BLLN documents · BLLN ownership · BLLN peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.